Access Menu

Log in via Social

Log in with LinkedIn
Archimedes' Offspring

Archimedes' Offspring

There's a Sea-Change Coming - We're Reinventing Inventing: Direct Investments in Thoroughly-Vetted, High-Quality Inventions

Verify Investor Status to make a reservation

Deal Type

Equity

Funding Goal

$750,000

Current Reservations

$1,000

Minimum Reservation

$1,000

Maximum Reservation

$750,000

Deal Stage

Series A

Pre-money Valuation

$1,500,000

Open Date

02/19/2020

Closing Date

05/31/2020

Deal Exemption Type

3

Elevator Pitch

We're re-inventing inventing by helping ideas go from mind to market without any detours.

KPIs

1,000 Users

Company Overview

Who or what is Archimedes’ Offspring?

Archimedes’ Offspring and the Invention Investment Families

Archimedes’ Offspring (AOS) is a trust(1) set up for the benefit of the Invention Investment Families.

What are the Invention Investment Families?

The Invention Investment Families (IIFs) are a series of investment funds created by AOS to receive investments made by ordinary investors in one or more of the IIFs in connection with the acquisition by the IIFs of a percentage ownership interest in new ideas and inventions. The IIFs accomplish this by directly investing in such ideas and inventions themselves, instead of the companies in which those ideas and inventions may be housed (i.e., “direct investments in inventions, not startups”). This enables each IIF to avoid registration as an “investment company” under the Investment Company Act of 1940, as amended, and, in the process to, quite literally, “reinvent” the inventing process itself. For more information on the various IIFs, the reader is directed to the AOS PowerPoint, which you can find —> here

Because of the new way AOS will shepherd ideas and inventions through the developmental stage to commercialization, AOS is convinced that the returns on such investments will exceed those typically achieved by the average successful independent inventor (which historically has run, on average, at an 11.5% internal rate of return (IRR)), as well as those available, over the longer term, from other alternative investments, such as venture capital, private equity investing and real estate investment trusts.

AOS’s targeted goal for such returns is 20% or higher. AOS believes that by applying the new AOS process (coupled with adequate funding), the returns typically realized by successful independent inventors can be nearly doubled.

To find out more about the IFFs, and how you can become an investor, please continue reading to the bottom of this page. In the alternative, you can read the “Investor FAQs” which you can find –> here.

86adeb4cc32877feca2e27dcdae29bb9.jpg

Archimedes at that moment of “illumination”

Introduction

As we are all well aware, the world economy is changing fundamentally at a dizzying pace. Countries like Brazil, Russia, India and China (the so-called “BRIC” Block that we’ve heard so much about over the past several years) have become potent economic adversaries and, until most recently, have been growing their economies at double digit rates. At the same time, while at present the U.S. economy is excelling, this (temporary) national resurgence is not being evenly shared among the various state economies. In addition, as a mature economy, the U.S. over the past several decades has only experienced modest rates of growth.

Unfortunately, the American way of doing business has been successfully duplicated at this point in each of these accelerated economies; our traditional competitive advantages (i.e., technology superiority, educated workforce, economies of scale, manufacturing efficiency, etc.) are disappearing as foreign economic fortunes improve and educational and employment opportunities increase abroad. The U.S. economy, for the first time in its history, finds itself under siege by a tidal wave of competition that shows no signs of abating.

Consequently, as we look to our economic future here in this country, it’s essential that we uncover, or rediscover, ways in which to inject vitality and genuine competitive advantage into an economy that has seen better times. An important avenue for gaining such vitality and advantage is through innovation: the inventor is an essential part of this process.

The American Inventor

“Inventors are visionaries with a poorly developed sense of fear and no concept of the odds against them. They make the impossible happen.”

———–Robert Jarvik (first artificial heart)

In the past, American inventors have shown that they know no limits. Inventors of any age, and all genders and races, have contributed to the creative genius that is the American inventing process. The technology envisioned by American inventors has improved our standard of living and linked us across both physical and cultural divides.

a767e73fc18f2f664e60089586cd086b.jpg

For some perspective on the magnitude of the inventing community in America, note that from 1790 (when the U.S. Patent Office was first established) up through the middle of November of 2018, the U.S. Patent and Trademark Office had granted more than 10 million patents. By some calculations, at any point in time, there are over 1 million active inventors in the United States (i.e., individuals who have gone as far as to file for a patent), with an additional 11 million who consider themselves as “innovators” but, for one reason or another (e.g., fear of failure, lack of money, lack of support among family members, etc.) have failed to take those important first steps toward realizing their inventing dreams.(2)

Innovation and the inventing process, along with the inventors themselves, have been the key ingredients in driving the growth of the American economy over the past two hundred years. They are a vital component of the U.S. competitive arsenal. And, as important is the fact that inventors don’t just innovate; they create wealth, use the services of other providers and give back to the community. They are both drivers and users of the economy; they both create and consume.

We at AOS believe it’s time to encourage and support these innovative people who are dedicated to the inventing process. We believe that supporting them and their processes holds the potential for revitalizing our economy. It’s the recognition of this inescapable fact that has served as the impetus for the creation of Archimedes’ Offspring.


U.S. Patent Activity Calendar Years 1972 to 2015

What’s in it for the Investor?

Historically

— Chances for Inventor Success

Unaided, on their own, and without professional mentoring (other than, perhaps, a patent attorney whose interests in the client’s financial welfare may be a secondary consideration next to the fees available for the rendering of patent preparation and prosecution services), independent inventors have an extremely difficult row to hoe. While estimates of independent inventor success rates vary all over the lot, from less than 0.1 percent by some estimates to as high as 50% by others, independent, impartial and empirical studies have placed the number at closer to 6.5% ([+ or -] 0.7%).(3)

Thus, without:

-- the benefit of close-monitoring of the inventor's inventing process by experienced and knowledgeable mentors who serve as "task masters",

-- involvement by reputable professionals from the specific industry being targeted as "vetters" of the idea / invention, and

-- the funds necessary to carry out the basic tasks and functions required to bring the invention and its related intellectual property to fruition,

less than 7% of independent inventors will ultimately be successful in commercializing their invention.

— Internal Rate of Return (IRR)

Consistent with the above, additional independent, impartial and empirical research has determined that without in-depth support, the average independent inventor who ultimately proves to be successful on his or her own (i.e., conditional on successful commercialization), can be expected to receive approximately a 16% internal rate of return on their investment.(4)

Although this number drops down to 11.4% when you factor in the traditional concerns about the probability of successful commercialization and the quality of the inventive efforts, what this demonstrates more than anything else is the need for (i) expert and reputable professional help, mentorship and supervision, (ii) extraordinary involvement by industry professionals in the vetting process, and (iii) sufficient monetary resources to see the project through to fruition.


Comparison with Other Investments

– Comparison with Speculative Investments (Venture Capital)

Admittedly, the foregoing might not be the type of return of which venture capitalists and high-net-worth investors dream. However, once you factor in the extremely high risk profile (i.e., rate of failure of startups in general) attributable to the average venture capital investment, it is clear that, at least from the perspective of the ordinary investor, investing directly in inventions holds out the promise of producing superior returns.

Along these lines, it is a well-known fact that, on average, only 1 out of 10 companies in which venture capitalists invest will produce an out-sized return, with the performance of the balance of the venture capitalist’s portfolio proving disappointing. When you couple that with an 80% to 90% failure rate of venture capital firms themselves, the risk from investing in inventions is far lower, with the promised benefit, more often than not, clearly outweighing the risk. Lastly, it’s important to note that portfolio companies, not infrequently, absorb several millions of dollars before failing. By comparison, the maximum loss an investor in one of the AOS Invention Investment Families can experience with respect to a single invention is small, i.e., $75,000.

– Comparison with Traditional Investments

Unfortunately, when it comes to traditional alternatives such as the public markets, REITs, stock/bond mixed portfolios, gold, straight bonds, etc., the comparison with investing directly in inventions suffers even more. See the chart below.

How AOS Will Re-Invent Inventing and Drive Performance and Return

One thing upon which everyone can agree is that having professionals onboard, with real expertise, who can evaluate new concepts (whether those concepts involve landing on the moon, designing and manufacturing a new fighter jet, executing the legal, business, accounting and tax strategic planning required to create, grow and sustain a complex, new business entity, or even making investments in the venture capital or private equity markets), is always a good thing and a very smart move.

And, while the mere involvement of an experienced professional in a process won’t, by itself, assure a positive outcome, when present, that professional significantly helps to increase chances for success. When you couple that expertise and professional diligence with the additional industry and financial resources needed to bring an idea to fruition, the chances for success increase exponentially and the failure rate plummets. It’s this approach that drives the business model undergirding the AOS project.

Once you apply a team of extremely experienced, reputable and honest service provider professionals (consisting of experts in patent and product searching; patent evaluation; preparation and prosecution of patent applications; prototyping and design engineering; short-run manufacturing; and trade show attendance and marketing) to the process and, then, cap it with a vetting system that ensures product industry participation in the final decision-making, the picture (and the chances for success) looks very different.

This is the central premise of the AOS business model: that honest and reputable professional expertise, coupled with committed and diligent mentorship and supervision and sufficient funds to see the project to completion, will increase the success rate by several orders of magnitude, resulting, not only in a greatly improved success rate, but a success rate with a much greater return, not only for the inventor, but for whomever invests alongside that inventor.

This is the central premise of the AOS business model: that honest and reputable professional expertise, coupled with committed and diligent mentorship and supervision and sufficient funds to see the project to completion, will increase the success rate by several orders of magnitude, resulting, not only in a greatly improved success rate, but a success rate with a much greater return, not only for the inventor, but for whomever invests alongside that inventor.

Top 12 Reasons for Investing with Archimedes’ Offspring

Thus to sum up, here’s some of the major reasons why investing with one or more of the AOS Invention Investment Families instead of existing speculative, or even traditional, investments makes eminent sense:

1. Lower Risk Investments: The money is invested in “lesser-risk” inventions (i.e., maximum investment per invention limited to $75,000) versus “higher-risk” startups (i.e., downside, potential, the loss of several million dollars per failed startup).

2. Direct Investment in Inventions, Not. Startups: Investments made in inventions is for something “concrete” i.e., partial ownership (% subject to negotiation) of title to an invention and its related intellectual property, not securities in a startup company.

3. Investment Levels Capped: Maximum capital invested in any single invention is $75,000, invested in three separate tranches – for each tranche for which investment is approved, an additional % of ownership in the invention is surrendered (projected aggregate average: 20%)

4. Inventor Commits to Exit Strategy Before Funding Occurs: Inventor must agree to exit through licensing or outright sale to a third party – but is permitted to (i) repay the amount with interest at a rate negotiated at the time the “bridge loan” is made (i.e., 15% per annum or above), or (ii) come back to AOS if the invention is “one in a million” and the inventor is seeking permission to create a company to commercialize the invention by seeking private funding (other than AOS) to grow it. In such a case, the inventor must “buy back” his invention and the related IP rights at a price to be determined at the time of “buy back” based on the valuation of the idea or invention existent at the time of such buy back, determined by a professional appraisal and reaching a mutually-satisfactory “buy-back” agreement.

5. "Well-Below Market" Management Compensation: Under the terms of the Management Contract, investment managers (which includes all senior-level staff positions) will get reasonable, but modest, compensation (payable by AOS Management, Inc., but subject to reimbursement by the IIFs acting on a joint and several basis), of up to, but no more than, $5,000 per month per individual, with such monthly compensation permanently capped at that level, subject to increase only in the event of a vote to increase that amount which is favored by at least 51% of all of the shareholders of all of the IIFs voting, collectively, as a single class. It is anticipated that, initially, there will be 6 such positions, but in any event, not more than 10 positions at any point in time.

6. Management "Carried Interest" is Modest and Below Industry Norms: Under the terms of the Management Contract AOSM will receive nineteen percent (19%) of each IIF’s outstanding capital in the form of shares of Series B Preferred Stock. Such stock will possess an anti-dilution preference, but will otherwise be subject to a liquidation preference in favor of the Series A Preferred Stock described in Item No. 10 below. AOS intends that all shares of Series A Preferred Stock will be owned by the investors in an IFF’s initial securities offering, which AOS believes will consist of members of the general investing public.

7. Administrative Overhead for the IIF Funds is Eliminated: AOSM Managers manage day-to-day operations of the IIFs' funds, subject to supervision and approval by IIF’s funds' Boards of Directors. No officers or staff required for the IIFs or their funds.

8. Early Investors are Rewarded by Preferences, Protections and Discounts: Since each of the IIFs can raise multiple rounds of capital, doing offerings, on average, every 12 months and, under extraordinary circumstances, as often as every 6 months, early investors are rewarded by both preferred terms and subsequent rounds of capital supporting their initial investment.

9. The General Public Can Invest; Investments Are Not Limited to the Very Rich: Money is raised from the general public through innovative use of new Federal Title III and Title IV “public offerings” under the JOBS Act.

10. Early Investors Get Their Capital Back First: In every initial securities offering by an IIF, the investors in such initial offering (which, in every case, will be a Series A Preferred Stock offering), will receive one hundred percent (100%) of their capital back prior to any distribution to the investment managers or the remaining shareholders.

11. No Additional or Hidden Fees: There are no additional fees. AOSM is entitled to receive reimbursement of moderate, reasonable and necessary business expenses incurred by AOSM on behalf of the IIFs (i) in the running and maintaining the IIFs’ businesses, and (ii) for capital expenditures incurred to improve the IIFs' business operations.

12. Enhanced, Above Market Returns with Lower Risk: Given the smaller, maximum amount of money invested (i.e., $75,000) per investment opportunity, AOS represents, potentially, a tremendous opportunity for a greatly enhanced rate of return at a much lower risk profile than, say, speculative securities or venture capital-funded portfolio companies).

To put it simply, in the opinion of AOS and its designee, AOSM, the invention portfolio pool is much more favorable than either traditional investments or even other speculative alternative investments since with the AOS invention portfolio pool risk is spread over many, many more investments than is possible under, say, the venture capital model, where the average venture capital fund cannot invest in more than 30 portfolio companies per fund raised.

We believe that investments in AOS-sponsored IIFs will prove to be, over the longer-term, a superior investment over both traditional and speculative alternative investments. We’re excited to bring this brand new, innovative concept to investing within the next few months. Stay tuned to learn more about AOS-sponsored IIF opportunities to be offered in the near future.

In the meantime, if you’d like to better understand the AOS business model, take a gander at the AOS PowerPoint, which you can find —> here.

“Testing-the-Waters” – Potential Future Offerings

In the future, we intend to work with one or more of the IIFs in one or more “testing-the-waters” campaigns in connection with potential future securities offerings under the exemption from registration afforded by Regulation A, as amended, of the Federal Securities Act of 1933, as amended. For details pertaining to such potential future securities offering, the reader is directed to subscribe to the newsletter sent out from time-to-time to regular subscribers to this website.


1 Archimedes’ Offspring is an unincorporated business organization (commonly referred to as a “Massachusetts Business Trust” or “MBT”) formed pursuant to that certain Trust Agreement dated as of the 31st day of March, 2019 (the “Trust Agreement”), by and between FLC LLC, a Colorado limited liability company doing business as “FLeCusa International,” as Grantor (the “Grantor”), Windom Peaks Capital, LLC, a Colorado limited liability company, as Trustee (the “Trustee”), and the Invention Investment Families identified elsewhere on this website (the “IIFs”), each of which has been designated a beneficiary / beneficial owner under the terms of the Trust Agreement.

Under the terms of the Trust Agreement, the Trustee (subject to approval by the Board of Directors of each of the IIFs at the time of the First Organizational Meeting of such IFF’s Board) has appointed AOS Management, Inc. (“AOSM”) as the management company designee for each of the IIFs. The compensation to be paid to AOSM for the management tasks which it will be required to perform under the management agreement to be entered into between AOS and AOSM on behalf of the Trust, for the benefit of the IIFs (the “Management Contract”), which includes the equity participation by AOSM in each of the IIFs, is detailed, in each case, in the disclosures pertaining to the Management Contract which can be found in the forms required to be filed with the Securities and Exchange Commission prior to the commencement of an offering of any securities by any of the IFFs.

2 Source: Adam Davidson “Searching for the Next Snuggie: Is this Really the Golden Age for Inventors?” The New York Times Magazine, April 17, 2012. The United States Patent and Trademark Office (the “USPTO”) issued a report in February 2016, in which, based on official records, they indicated that there were a total of 739,264 Independent Inventors in the United States as of 2015. See “Independent Inventors by State by Year All Patents, All Types Report January 1, 1977 ‐ December 31, 2015”, U.S. Patent and Trademark Office, February 2016.

3 Source: Thomas Astebro, “Basic statistics on the success rate and profits for independent inventors”, Entrepreneurship: Theory and Practice, December 22, 1998. Also, see, Andrew Spriegel, “Invention Success Rates | Odds of Inventor Success”, Andrew.Spriegel’s Blog, November 24, 2010.

4 Source: Thomas Astebro, “The Return to Independent Invention: Evidence of Unrealistic Optimism, Risk Seeking or Skewness Loving”, The Economic Journal, Volume 113, Issue 484, 1 January 2003, Pages 226–239.

Traction

  • United States Patent and Trademark Office (USPTO) Pro Bono Program submits first potential inventor candidate to AOS Vetting Process

    January, 2020
  • AOS President and CEO, Rita Crompton, appointed Ambassador under United Inventor Association Ambassador Program

    January, 2020

Pitch Deck

Press Mentions

Key Customers & Partners

The Inventor Lady The Inventors' Roundtable Colorado Crowdfunding Windom Peaks Capital, LLC FLeCusa International C5 Eureka Holdings, LLC United Inventors Association USPTO Patent Pro Bono Program Inventors Launchpad NCH Avid Product Development Blacksmith International Lochner International Inventors Association of New England HomeTalk Stander

Previous Funding

  • $10,000 Equity
  • Raise Source: Investors
  • February 2020
  • $40,000 Equity
  • Raise Source: Investors
  • October 2019
  • $30,000 Debt
  • Raise Source: Investors
  • October 2019

Frequently Asked Questions

Questions and Answers:

Review our "Investor Q&As". You can find them here: https://www.crowdfunder.com/archimedes-offspring/invest#

Risks & Disclosures

Risks

1

Our future success depends on the efforts of a small management team. The loss of services of the members of the management team may have an adverse effect on the company. There can be no assurance that we will be successful in attracting and retaining other personnel we require to successfully grow our business.

2

As a combined investment and product development business, we carry risks attendant in both industries. These can include, but are not limited to, professional errors and omissions risk, professional malpractice, risk of loss of an investor's entire investment, product liability and other legal liability issues, . While our team undergoes thorough training, these risks are magnified, but will continue even after the period of training concludes.

3

In order to maintain a good investor relations and inventor satisfaction, we need to perform at above normal industry standards. Optimal results, both from the inventor's as well as the investor's perspective are critical to the continued welfare of the business and to our ability to raise additional investment funds in the future from our retail investor target demographic.

4

Our business model relies on a network of operations partners, such as industry-experienced, expert members of our vetting committees, service providers who perform at superior levels and contract employees who are dedicated and engaged in making our businesses successful. Over time, our rapid growth might put a strain on our various partners' and contract employees ability to scale. If our partners are unable to scale at a pace that is proportional to ours, we'll have to either rapidly find new partners or slow down the then current pace of growth to accommodate the development until we are able to place new partners in place .

5

We are building a business in a competitive market. And to succeed, we'll need to build a compelling brand that can stand out. This will require capital and human resources. And an inability to raise funds will hamper our ability to grow.

6

The Company may never receive a future equity financing or elect to convert the securities upon such future financing. In addition, the Company may never undergo a liquidity event such as a sale of the Company or an IPO. If neither the conversion of the securities nor a liquidity event occurs, a purchaser could be left holding those securities in perpetuity. The securities have numerous transfer restrictions and will likely be highly illiquid, with no secondary market on which to sell them for the foreseeable future.

We believe it is vitally important that you read and fully understand the risks associated with investing in general. Below are some of the most common ones:

INVESTMENT RISKS:

All investments, including investing in inventions and associated intellectual property, is speculative in nature and involves a substantial risk of loss. It is very important for our investors to be cognizant of this fact.

We encourage investors to get personal advice from their own professional investment advisors and to make independent investigations before acting on information that we publish. In this regard, it is important to remember that much of our information is derived directly from information published by others or submitted to governmental agencies. While we believe that the information upon which we base our conclusions is reliable, we have not independently verified such information. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements.

Additionally, it is important to remember that past performance is not necessarily indicative of future results. There is no guarantee that, based on past experience, current systems, indicators, or signals will result in profits or that they will not result in losses. For example, unless specifically noted otherwise, all return examples provided in our websites and publications are based on projections we’ve made relying on information provided by others and our own understanding of the nature and size of our markets, our competitors, and how well we, and our competitors, have performed in relation to other indexes and other alternative investments. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because, as we’ve stated, past performance is not necessarily indicative of future results.

Don’t enter any investment without fully understanding the worst-case scenarios of that investment.

FORWARD LOOKING STATEMENTS:

Various statements contained on this landing page, including those that express a belief, expectation or intention, as well as those that are not statements of historical fact, are forward-looking statements. These forward-looking statements may include projections and estimates concerning the timing and success of strategies, plans or intentions. We have based these forward-looking statements on our current expectations and assumptions about future events. These assumptions include, among others, our projections and expectations regarding:

  • market trends in the inventing industry and, more specifically, the mass aggregator segment within that industry;
  • market trends in the markets where we have invested substantial sums of money in intellectual property covering the products in those markets;
  • our business strengths;
  • the ideal invention profile;
  • the quality of the inventions in which the AOS-sponsored funds have invested;
  • our ability to create a cash flow opportunity with both historical and, hopefully, improved, yields in the inventing industry; and
  • upside from increasing (i) license fees, (ii) intellectual property sales, (iii) IP-related bridge loans, and (iv) buybacks by inventors previously funded by one of the AOS-sponsored funds;
  • cost efficiencies;
  • our understanding of our competition; and
  • general economic, demographic conditions that may impact our business.

While we consider our expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control and could cause actual results to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Investors should not place undue reliance on these forward-looking statements. We undertake no obligation to update any forward-looking statements to conform to actual results or changes in our expectations, unless required by applicable law.

RISKS RELATED TO THE INVENTING INDUSTRY AND THE MASS AGGREGATION OF IP

An investor’s performance and the value of the properties in which we invest are subject to general economic conditions and risks associated with being in a business involving the mass aggregation, licensing and sale of intellectual property assets.

There are significant expenditures associated with investments in inventions (such as development and commercialization expenses pertaining to specific inventions, and, in general, debt service, taxes, insurance and maintenance costs) that generally do not decline when circumstances reduce the income from the ultimately developed and commercialized intellectual property assets. Income from and the value of these assets may be adversely affected by the following factors:

  • downturns in international, national, regional and local economic conditions (particularly increases in unemployment);
  • the attractiveness of the intellectual property assets acquired to potential licensees and competition from similar assets owned by competitors;
  • increases in the supply of or decreases in the demand for similar or competing assets in our target markets;
  • bankruptcies, financial difficulties or defaults by licensees;
  • changes in interest rates, availability and terms of debt financing;
  • changes in operating costs and expenses;
  • changes in, or increased costs of compliance with, governmental laws, rules, regulations and fiscal policies, including changes in tax and environmental laws, and our and our inventor clients’ potential liability thereunder;
  • our ability to provide adequate maintenance of our interest in our intellectual property assets;
  • changes in the cost or availability of insurance;
  • licensee turnover;
  • the illiquidity of investments in alternative assets generally, and in intellectual property assets in particular;
  • prospective licensee’s perceptions of the attractiveness of our properties and how they were acquired;
  • the ongoing need for improvements on existing patents in the form of continuations in part, particularly in older properties;
  • the ability or unwillingness of licensees to pay increases in previously-negotiated licensee fees;
  • civil unrest, acts of God, including earthquakes, floods and other natural disasters, which may result in uninsured losses, and acts of war or terrorism;
  • the potential for a challenge to the legitimacy of our intellectual property assets and attempts, both successful and unsuccessful, to have one or more of those properties invalidated by the Patent Trials and Appeals Board or by a court.
  • Unanticipated increases in property maintenance and operating expenses.

For these and other reasons, we cannot and does not make any guarantees to investor performance.

Archimedes’ Offspring faces significant competition in the licensing and IP aggregation and sales markets for both quality inventions and quality licensees. This may limit our ability to license or sale our intellectual property assets on favorable terms or at all.

We face competition for both inventors and licensees from other mass aggregators of intellectual property assets. Many of our competitors may successfully attract inventors and their inventions with better incentives and perquisites, which could adversely affect our ability to obtain quality inventions and license our intellectual property assets on favorable terms or at all. Additionally, some competing inventions and related intellectual property may qualify for government subsidies that may make such options more affordable and therefore more attractive to licensees, purchasers and other third parties than our own offerings.

DISCLAIMER:

All calculations and data presented within the AOS publications and digital marketing and media including but not limited to websites, brochures, presentations and return models are deemed to be accurate, but accuracy is not guaranteed. The projected pro forma returns on investment are intended for illustrative purposes only in order to facilitate analysis and are not guaranteed by Archimedes’ Offspring or its affiliates, if any. As we’ve already stated, past performance is not an indicator of future results.

The information provided herein is not intended to replace or serve as a substitute for any legal, real estate, tax, or other professional advice, consultation or service. You should consult with a professional in the respective legal, tax, accounting, real estate, and other professional areas before making any decisions or entering into any contracts pertaining to the securities described herein.

All marketing and media material has been prepared to provide summary, unverified information to prospective investors, and to establish only a preliminary level of interest in the offering made herein.

Additionally, the information contained herein is not a substitute for a thorough due diligence investigation. AOS has not yet had an opportunity to make an investigation, and makes no warranty or representation, with respect to the income or expenses for the development and commercialization of any specific invention displayed on this landing page or on any AOS-sponsored websites, publications or other materials disseminated to the general public.

Documents

Confidential

Loading...